Target intelligence / Profile preview

Cell membrane permeability inhibitor

Molecular classification
Other
01

Overview

\"Cell membrane permeability inhibitor\" does not refer to a unique molecular entity or protein but is a descriptive category encompassing any compound or intervention that reduces or blocks the movement of substances across the cell membrane. This can include some small molecules, peptides, or nanoparticles designed to restrict entry of drugs, toxins, or ions into the cell. The term is sometimes used in drug discovery to describe an undesired characteristic when evaluating absorption, distribution, and bioavailability of candidate drugs. In mitochondrial research, \"mitochondrial permeability transition pore inhibitors\" are a related but more specific target class, with well-studied members such as cyclosporin A, but \"cell membrane permeability inhibitor\" itself is not a canonical target name.

Other names
Membrane permeability inhibitorInhibitor of cell membrane permeability
02

Mechanism of action

Decreases or blocks permeability of the cell or organelle membrane to ions, drugs, or other molecules (general mechanism, not target-specific) \n Some small molecules, peptides, or other agents may act as \"membrane permeability inhibitors\" by modifying lipid bilayer dynamics or blocking specific channels

03

Biological functions

Regulates or restricts transport of molecules across cell membranesMay reduce drug uptake or block entry of toxins
04

Disease associations

Other
05

Safety considerations

Off-target effects on essential membrane transportPossible interference with cellular homeostasis or normal pharmacokineticsCytotoxicity if inhibition is too broad or potent

Beyond the preview

Go deeper on Cell membrane permeability inhibitor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell membrane permeability inhibitor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call